Increased Interleukin-35 Levels in Patients With Type 1 Diabetes With Remaining C-Peptide

Diabetes Care - United States
doi 10.2337/dc16-2121
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Diabetes Association

Related search

Amelioration of Sensory Nerve Dysfunction by C-Peptide in Patients With Type 1 Diabetes

Diabetes
Internal MedicineEndocrinologyMetabolismDiabetes
2003English

Factors Associated With Increased Irisin Levels in the Type 1 Diabetes Mellitus

Endocrine Regulations
EndocrinologyMetabolismDiabetes
2017English

Serum Levels of Interleukin 10 (IL-10) in Patients With Type 2 Diabetes

Clinical Biochemistry
MedicineClinical Biochemistry
2011English

Increased Plasma Concentrations of Interleukin 35 in Patients With Coronary Artery Disease

Archives of Medical Science
Medicine
2017English

Basal and Postglucagon C-Peptide Levels in Ethiopians With Diabetes

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2002English

Residual C-Peptide Secretion and Endothelial Function in Patients With Type II Diabetes

Clinical Science
Medicine
2003English

C-Peptide Exerts Beneficial Effects on Myocardial Blood Flow and Function in Patients With Type 1 Diabetes

Diabetes
Internal MedicineEndocrinologyMetabolismDiabetes
2002English

Pregnancy-Induced Rise in Serum C-Peptide Concentrations in Women With Type 1 Diabetes

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2009English

PCSK9 Is Increased in Youth With Type 1 Diabetes

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy